Total synthesis of the isoquinolinium metabolite ETM-204 of Trabectidin

Christian Lembacher-Fadum, Simon Gissing, Georg Pour, Rolf Breinbauer*

*Korrespondierende/r Autor/-in für diese Arbeit

Publikation: Beitrag in einer FachzeitschriftArtikelBegutachtung

Abstract

Ecteinascidin-743 (Trabectidin, Trabectedin ®, Yondelis ®) is a synthetically obtained pharmaceutical drug originally isolated from a marine tunicate. Trabectedin is used for the chemotherapy of soft-tissue sarcoma and ovarian cancer. The isoquinolinium metabolite ETM-204 has been found in biotransformation and degradation studies of Trabectedin. We report the first total synthesis of ETM-204 and its full spectroscopic characterization confirming the postulated structure. Central elements of the 12-step synthesis starting from 2-methyl-6-nitrophenol are a Cu-mediated conversion of an iodoarene to a phenol, a Skattebøl-formylation, and a modified Pomeranz–Fritsch cyclization to assemble the isoquinoline ring. The pH-dependence of its visual absorbance could be clarified. Graphic abstract: [Figure not available: see fulltext.]

Originalspracheenglisch
Seitenumfang11
FachzeitschriftMonatshefte für Chemie - Chemical Monthly
DOIs
PublikationsstatusElektronische Veröffentlichung vor Drucklegung. - 2021

ASJC Scopus subject areas

  • Chemie (insg.)

Fields of Expertise

  • Human- & Biotechnology

Fingerprint

Untersuchen Sie die Forschungsthemen von „Total synthesis of the isoquinolinium metabolite ETM-204 of Trabectidin“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren